FIELD: medicine.
SUBSTANCE: invention refers to pharmacology, medicine and concerns using Trecresan as a PGC-1 coactivator gene expression stimulator.
EFFECT: invention leads to increasing mitochondrion count in muscular tissue, growing performance of striped muscles.
2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTANCE STIMULATING GENE EXPRESSION OF COACTIVATOR PGC-1α | 2014 |
|
RU2559779C1 |
| AGENT STIMULATING EXPRESSION OF MATRIX RNA OF TRYPTOPHANYL-tRNA-SYNTHETASE | 2010 |
|
RU2429836C1 |
| USING ZINC COMPLEX-TRIS-(2-HYDROXYETHYL)AMINE WITH BIS-(2-METHYLPHENOXYACETATE) (ZINCATRANE) FOR STIMULATING EXPRESSION OF MATRIX RNA OF TRYPTOPHANYL-tRNA-SYNTHETASE | 2014 |
|
RU2540469C1 |
| HERMATRANOL HYDRATE STIMULATING TRYPTOPHANYL-TRNA-SYNTHETASE MATRIX RNA EXPRESSION | 2014 |
|
RU2553986C1 |
| APPLICATION OF PROTATRANE 4-CHLORO-2-METHYLPHENOXIACETATE (CHLORCREZACINE) FOR TRYPTOPHANYL-tRNA-SYNTHETASE MATRIX RNA EXPRESSION STIMULATION | 2016 |
|
RU2623035C1 |
| METHOD OF ASSESSMENT OF GENE EXPRESSION OF TRYPTOPHANYL - TOTAL RNA SYNTHETASE AS MARKER OF OVERWORK DURING TRAINING OF ATHLETES - STATE OF OVERTRAINING | 2013 |
|
RU2521655C1 |
| AGENT MODULATING ACID PHOSPHOLIPASE A1 ACTIVITY | 2010 |
|
RU2445087C1 |
| AGENT TO DECREASE CHOLESTEROL ESTERASE ACTIVITY | 2010 |
|
RU2444357C1 |
| COMPOSITIONS CONTAINING AMINO ACIDS FOR USE IN TREATMENT OF DISEASES ASSOCIATED WITH MITOCHONDRIAL DISFUNCTIONS | 2018 |
|
RU2778296C2 |
| AGENT FOR TOTAL TRYPTOPHANYL-tRNS-SYNTHETASE ACTIVATION | 2009 |
|
RU2407526C1 |
